Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results: 1-10 of 1,775

Trump Administration Lifts Ban On Biotechnology Crops In Wildlife Refuges

Bergeson & Campbell PC
USA
August 17 2018

On August 2, 2018, the Trump Administration’s Principal Deputy Director of the U.S. Fish and Wildlife Service, Gregory J. Sheehan, reversed an Obama

AbbVie Files Suit Against Sandoz Alleging Infringement of Two Humira-Related Patents

Rothwell, Figg, Ernst & Manbeck, PC
USA
August 14 2018

On August 10, 2018, AbbVie, Inc. and AbbVie Biotechnology Ltd. (collectively “AbbVie”) sued Sandoz Inc., Sandoz GMBH, and Sandoz International GMBH

Life sciences: product regulation and liability in Turkey

NSN Law Firm
Turkey, Global
July 11 2018

A structured guide to product regulation and liability laws in Turkey

Innovation key to driving success in healthcare

Boult Wade Tennant
USA, United Kingdom
July 3 2018

As the NHS turns 70, it is notable that the focus for the future is on innovation for the improvement of patient care. Technologies spanning genetic

PTAB Denies Another IPR Petition Relating to Adalimumab

Rothwell, Figg, Ernst & Manbeck, PC
USA
June 14 2018

The Patent Trial and Appeal Board (“PTAB”) recently denied Sandoz’s petition for inter partes review (“IPR”) of claims 1-30 of AbbVie’s patent, U.S

Capital Markets Alert - Public Market Advocacy Groups Release Guidance

Skadden Arps Slate Meagher & Flom LLP
USA
May 10 2018

On April 27, 2018, the Securities Industry and Financial Markets Association (SIFMA), the U.S. Chamber of Commerce and Nasdaq, along with certain

The Budget 2018-2019: our three key areas for intellectual property

King & Wood Mallesons
Australia
May 9 2018

Biotechnology companies and generic pharmaceuticals are the winners and celebrities are the Biggest Losers in some intellectual property-related

Hong Kong Launches New Rules on Biotech Listings

Slaughter and May
Hong Kong
May 8 2018

The Stock Exchange of Hong Kong Limited (the Exchange) has concluded its consultation on a listing regime for emerging and innovative companies and

New chapter on listing of pre-revenue biotech companies in HK: At a glance

Deacons
Hong Kong
May 4 2018

On 24 April 2018, The Stock Exchange of Hong Kong Limited (the “Exchange”) published the consultation conclusions and announced the new rules to: (a

New Hong Kong Dual-Class and Biotech Companies Listing Regime

Latham & Watkins LLP
Hong Kong
May 3 2018

Hong Kong Stock Exchange introduces new listing regime for pre-revenue biotech companies and innovative companies with weighted voting rights

Current Search

Refine

Content type

Tags